Reduced Rate of Hospital Admission for Exacerbation of COPD and Asthma During COVID-19 Pandemic

References (8)

1. Çakır Edis E. Chronic pulmonary diseases and the COVID-19 pandemic. Turk Thorac J. 2020
2. 21(5):345-349. [CrossRef] 2. Dubey S, Biswas P, Ghosh R, et al. Psychosocial impact of COVID-19. Diabetes Metab Syndr. 2020
3. 14(5):779-788. [CrossRef] 3. De Rosa S, Spaccarotella C, Basso C, et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID- 19 era. Eur Heart J. 2020
4. 41(22):2083-2088. [CrossRef] 4. De Filippo O, D'Ascenzo F, Angelini F, et al. Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy. N Engl J Med. 2020
5. 383(1):88-89. [CrossRef] 5. Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, severity and mortality associated with copd and smoking in patients with covid-19: A rapid systematic review and meta-analysis. PLOS ONE. 2020
6. 15(5):e0233147. [CrossRef] 6. Global Iniative for asthma. Global strategy for asthma management and prevention. Global Iniative for asthma. 2020. (available at: https://ginasthma.org) 7. Global Iniative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of COPD. 2019. (available at: https://goldcopd.org) 8. Gong K, Xu Z, Cai Z, Chen Y, Wang Z. Internet hospitals help prevent and control the epidemic of COVID-19 in China: Multicenter user profiling study. J Med Internet Res. 2020
7. 22(4):e18908. [CrossRef] 9. Vitacca M, Montini A, Comini L. How will telemedicine change clinical practice in chronic obstructive pulmonary disease?. Ther Adv Respir Dis. 2018
8. 1753465818754778. [CrossRef]